Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2018 06:00 ET | Source: Global Market Insights, Inc

Overhead Conductor Market will secure 2.6% CAGR to surpass $800 million By 2024: Global Market Insights, Inc.

Sellbyville, Delaware, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Global Overhead Conductor Market is poised to cross USD 800 Million by 2024, as reported in the latest study by Global Market Insights,...
September 25, 2018 02:00 ET | Source: Novartis Pharma AG

Novartis plant, bis 2022 im Zuge weltweiter Anpassungen der Produktion und der internen Dienstleistungen Stellen in der Schweiz zu reduzieren

Die weltweite Anpassung des Produktionsnetzes von Novartis kann bis 2022 einen Nettoabbau von rund 1000 Stellen in der Schweiz zur Folge haben. Dies ist Teil der bereits 2015 initiierten...
September 25, 2018 02:00 ET | Source: Novartis Pharma AG

Novartis poursuit la transformation à l'échelle mondiale de son réseau de fabrication et de ses activités de services, entraînant une réduction planifiée de ses effectifs en Suisse d'ici 2022

L'adaptation poursuivie du réseau mondial de fabrication de Novartis, basée sur la stratégie annoncée précédemment visant à consolider sa présence et à investir dans de nouvelles plateformes de...
September 17, 2018 01:15 ET | Source: Novartis Pharma AG

Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals

Alcon Experience Academy serves as umbrella for industry-leading training and educational resources for all eye care professionals New website houses a robust library of more than 500 videos,...
September 12, 2018 16:30 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery

ALPHARETTA, Ga., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for...
September 11, 2018 01:00 ET | Source: Novartis Pharma AG

Alcon confirme son engagement envers la Suisse en perspective de la scission proposée avec Novartis

Le siège social mondial sera basé à Genève à côté du bureau régional d'Alcon pour l'Europe, le Moyen-Orient et l'Afrique La société Alcon cotée en bourse sera enregistrée à Fribourg, où Alcon...
September 11, 2018 01:00 ET | Source: Novartis Pharma AG

Alcon bestätigt vor dem vorgeschlagenen Spin-off von Novartis das Engagement in der Schweiz

Der globale Hauptsitz wird räumlich zusammen mit dem Alcon Regionalbüro für Europa, den Nahen Osten und Afrika in Genf eingerichtet Das börsennotierte Unternehmen Alcon wird in Fribourg...
September 11, 2018 01:00 ET | Source: Novartis Pharma AG

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis

Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office The listed Alcon company will be incorporated in Fribourg, where Alcon already has...
September 04, 2018 17:57 ET | Source: Agios Pharmaceuticals, Inc.

Agios Announces Chief Executive Officer Succession Plan

- David Schenkein, M.D., Agios Long-Time Chief Executive Officer, to Become Executive Chairman, Effective February 1, 2019 - - Jacqualyn Fouse, Ph.D., to Succeed Dr. Schenkein as Chief Executive...
August 29, 2018 01:00 ET | Source: NOVARTIS FINANCE S.A.

Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation Basel, August 29, 2018 - Reflecting its uncompromising...